Skip to main content
Erschienen in: Current Rheumatology Reports 4/2012

01.08.2012 | PSORIATIC ARTHRITIS (O FITZGERALD AND P HELLIWELL, SECTION EDITORS)

What Have Genome-Wide Studies Told Us About Psoriatic Arthritis?

verfasst von: James Bluett, Anne Barton

Erschienen in: Current Rheumatology Reports | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

There is convincing evidence to suggest a strong genetic component to psoriatic arthritis (PsA), with studies reporting a 40-fold risk to first-degree relatives of patients with disease. However, compared with rheumatoid arthritis, our understanding of the genetic etiology of PsA is less well-developed. Only three modestly sized genome-wide association studies of PsA have been undertaken to date, but they have identified the HLA-C region, IL12B, TRAF3IP2, and FBXL19 genes as being associated with PsA susceptibility. Results of genome-wide association studies of psoriasis and rheumatoid arthritis have been used to identify candidate genes for subsequent testing in PsA and have led to the identification of additional susceptibility factors for PsA. Most show overlap with psoriasis, whereas the overlap with rheumatoid arthritis is less pronounced. However, two loci show strong evidence for association with PsA but not psoriasis: HLA-B27 and the IL-13 gene locus.
Literatur
1.
Zurück zum Zitat Gladman DD, Farewell VT, Pellett F, et al. HLA is a candidate region for psoriatic arthritis. evidence for excessive HLA sharing in sibling pairs. Hum Immunol. 2003;64:887–9.PubMedCrossRef Gladman DD, Farewell VT, Pellett F, et al. HLA is a candidate region for psoriatic arthritis. evidence for excessive HLA sharing in sibling pairs. Hum Immunol. 2003;64:887–9.PubMedCrossRef
2.
Zurück zum Zitat Myers A, Kay LJ, Lynch SA, Walker DJ. Recurrence risk for psoriasis and psoriatic arthritis within sibships. Rheumatology (Oxford). 2005;44:773–6.CrossRef Myers A, Kay LJ, Lynch SA, Walker DJ. Recurrence risk for psoriasis and psoriatic arthritis within sibships. Rheumatology (Oxford). 2005;44:773–6.CrossRef
3.
Zurück zum Zitat Chandran V, Schentag CT, Brockbank JE, et al. Familial aggregation of psoriatic arthritis. Ann Rheum Dis. 2009;68:664–7.PubMedCrossRef Chandran V, Schentag CT, Brockbank JE, et al. Familial aggregation of psoriatic arthritis. Ann Rheum Dis. 2009;68:664–7.PubMedCrossRef
4.
Zurück zum Zitat • Karason A, Love TJ, Gudbjornsson B: A strong heritability of psoriatic arthritis over four generations--the Reykjavik Psoriatic Arthritis Study. Rheumatology (Oxford) 2009, 48(11):1424–8. This provides convincing evidence for a genetic contribution to PsA and allows comparison of the genetic effect with RA. CrossRef • Karason A, Love TJ, Gudbjornsson B: A strong heritability of psoriatic arthritis over four generations--the Reykjavik Psoriatic Arthritis Study. Rheumatology (Oxford) 2009, 48(11):1424–8. This provides convincing evidence for a genetic contribution to PsA and allows comparison of the genetic effect with RA. CrossRef
5.
Zurück zum Zitat Liu Y, Helms C, Liao W, et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease Loci. PLoS Genet. 2008;4:e1000041.PubMedCrossRef Liu Y, Helms C, Liao W, et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease Loci. PLoS Genet. 2008;4:e1000041.PubMedCrossRef
6.
Zurück zum Zitat •• Huffmeier U, Uebe S, Ekici AB, et al.: Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet 2010, 42:996–999. This was the first well-powered GWAS of PsA; it identified a susceptibility gene, TRAF3IP2, and provided functional evidence about how the genetic variation may affect cell function. PubMedCrossRef •• Huffmeier U, Uebe S, Ekici AB, et al.: Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet 2010, 42:996–999. This was the first well-powered GWAS of PsA; it identified a susceptibility gene, TRAF3IP2, and provided functional evidence about how the genetic variation may affect cell function. PubMedCrossRef
7.
Zurück zum Zitat Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007;80:273–90.PubMedCrossRef Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007;80:273–90.PubMedCrossRef
8.
Zurück zum Zitat Stuart PE, Nair RP, Ellinghaus E, et al. Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat Genet. 2010;42:1000–4.PubMedCrossRef Stuart PE, Nair RP, Ellinghaus E, et al. Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat Genet. 2010;42:1000–4.PubMedCrossRef
9.
Zurück zum Zitat • Chandran V: The genetics of psoriasis and psoriatic arthritis. Clin Rev Allergy Immunol 2012, Jan 25. [Epub ahead of print]. This is a comprehensive summary of results of psoriasis GWAS to date. • Chandran V: The genetics of psoriasis and psoriatic arthritis. Clin Rev Allergy Immunol 2012, Jan 25. [Epub ahead of print]. This is a comprehensive summary of results of psoriasis GWAS to date.
10.
Zurück zum Zitat Stahl EA, Raychaudhuri S, Remmers EF, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010;42:508–14.PubMedCrossRef Stahl EA, Raychaudhuri S, Remmers EF, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010;42:508–14.PubMedCrossRef
11.
Zurück zum Zitat Bowes J, Ho P, Flynn E, et al.: Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort. Ann Rheum Dis 2012, Feb 10. [Epub ahead of print]. Bowes J, Ho P, Flynn E, et al.: Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort. Ann Rheum Dis 2012, Feb 10. [Epub ahead of print].
12.
Zurück zum Zitat Ellinghaus E, Stuart PE, Ellinghaus D, et al.: Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL. J Invest Dermatol 2011, Dec 15. doi:10.1038/jid.2011.415. [Epub ahead of print]. Ellinghaus E, Stuart PE, Ellinghaus D, et al.: Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL. J Invest Dermatol 2011, Dec 15. doi:10.​1038/​jid.​2011.​415. [Epub ahead of print].
13.
Zurück zum Zitat Nair RP, Duffin KC, Helms C, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009;41:199–204.PubMedCrossRef Nair RP, Duffin KC, Helms C, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009;41:199–204.PubMedCrossRef
14.
Zurück zum Zitat Thomson W, Barton A, Ke X, et al. Rheumatoid arthritis association at 6q23. Nat Genet. 2007;39:1431–3.PubMedCrossRef Thomson W, Barton A, Ke X, et al. Rheumatoid arthritis association at 6q23. Nat Genet. 2007;39:1431–3.PubMedCrossRef
15.
Zurück zum Zitat Musone SL, Taylor KE, Lu TT, et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet. 2008;40:1062–4.PubMedCrossRef Musone SL, Taylor KE, Lu TT, et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet. 2008;40:1062–4.PubMedCrossRef
16.
Zurück zum Zitat Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet. 2010;42:1118–25.PubMedCrossRef Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet. 2010;42:1118–25.PubMedCrossRef
17.
Zurück zum Zitat Winchester R, Minevich G, Steshenko V, et al.: HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum 2011, Oct 17. doi:10.1002/art.33415. [Epub ahead of print]. Winchester R, Minevich G, Steshenko V, et al.: HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum 2011, Oct 17. doi:10.​1002/​art.​33415. [Epub ahead of print].
18.
Zurück zum Zitat Eder L, Chandran V, Pellet F, et al. Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Ann Rheum Dis. 2012;71:50–5.PubMedCrossRef Eder L, Chandran V, Pellet F, et al. Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Ann Rheum Dis. 2012;71:50–5.PubMedCrossRef
19.
Zurück zum Zitat Ho PY, Barton A, Worthington J, et al. HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis. Ann Rheum Dis. 2007;66:807–11.PubMedCrossRef Ho PY, Barton A, Worthington J, et al. HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis. Ann Rheum Dis. 2007;66:807–11.PubMedCrossRef
20.
Zurück zum Zitat Ellinghaus E, Ellinghaus D, Stuart PE, et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet. 2010;42:991–5.PubMedCrossRef Ellinghaus E, Ellinghaus D, Stuart PE, et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet. 2010;42:991–5.PubMedCrossRef
21.
Zurück zum Zitat Strange A, Capon F, Spencer CC, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet. 2010;42:985–90.PubMedCrossRef Strange A, Capon F, Spencer CC, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet. 2010;42:985–90.PubMedCrossRef
22.
Zurück zum Zitat •• Duffin KC, Freeny IC, Schrodi SJ, et al.: Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. J Invest Dermatol 2009, 129:2777–83. This was the first study to show that stratification analysis of psoriasis GWAS might lead to identification of PsA-specific loci. PubMedCrossRef •• Duffin KC, Freeny IC, Schrodi SJ, et al.: Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. J Invest Dermatol 2009, 129:2777–83. This was the first study to show that stratification analysis of psoriasis GWAS might lead to identification of PsA-specific loci. PubMedCrossRef
23.
Zurück zum Zitat Bowes J, Eyre S, Flynn E, et al. Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris. Ann Rheum Dis. 2011;70:1016–9.PubMedCrossRef Bowes J, Eyre S, Flynn E, et al. Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris. Ann Rheum Dis. 2011;70:1016–9.PubMedCrossRef
24.
Zurück zum Zitat Eder L, Chandran V, Pellett F, et al. IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients. Ann Rheum Dis. 2011;70:1594–8.PubMedCrossRef Eder L, Chandran V, Pellett F, et al. IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients. Ann Rheum Dis. 2011;70:1594–8.PubMedCrossRef
25.
Zurück zum Zitat Marrakchi S, Guigue P, Renshaw BR, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365:620–8.PubMedCrossRef Marrakchi S, Guigue P, Renshaw BR, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365:620–8.PubMedCrossRef
26.
Zurück zum Zitat Bowes J, Orozco G, Flynn E, et al. Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Ann Rheum Dis. 2011;70:1641–4.PubMedCrossRef Bowes J, Orozco G, Flynn E, et al. Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Ann Rheum Dis. 2011;70:1641–4.PubMedCrossRef
Metadaten
Titel
What Have Genome-Wide Studies Told Us About Psoriatic Arthritis?
verfasst von
James Bluett
Anne Barton
Publikationsdatum
01.08.2012
Verlag
Current Science Inc.
Erschienen in
Current Rheumatology Reports / Ausgabe 4/2012
Print ISSN: 1523-3774
Elektronische ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-012-0255-5

Weitere Artikel der Ausgabe 4/2012

Current Rheumatology Reports 4/2012 Zur Ausgabe

PSORIATIC ARTHRITIS (O FITZGERALD AND P HELLIWELL, SECTION EDITORS)

Altered Bone Biology in Psoriatic Arthritis

SYSTEMIC LUPUS ERYTHEMATOSUS (JT MERRILL, SECTION EDITOR)

The Rationale for BAFF Inhibition in Systemic Lupus Erythematosus

PSORIATIC ARTHRITIS (O FITZGERALD AND P HELLIWELL, SECTION EDITORS)

Is Psoriatic Arthritis a Result of Abnormalities in Acquired or Innate Immunity?

SYSTEMIC LUPUS ERYTHEMATOSUS (JT MERRILL, SECTION EDITOR)

Belimumab and the Clinical Data

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.